SCHEMBL19396261

SCHEMBL19396261

Cc1cc(-c2cc(C)n(C)n2)sc1C(=O)N1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.43
ALDH1A1 P00352 8/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.42
HTR2C P28335 2/20 0.39
CES2 O00748 1/20 0.39
MAPK1 P28482 2/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
DUSP3 P51452 1/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1594256 0.85 ALDH1A1 (0.47) HPGDALDH1A1HSD17B10KDM4EPOLB
SCHEMBL17624645 0.81 MAPT (0.47) HPGDALDH1A1HSD17B10KDM4EPOLB
SCHEMBL19396259 0.78 NPC1 (0.44) HPGDALDH1A1HSD17B10KDM4EPOLB
SCHEMBL12195803 0.73 HPGD (0.53) HPGDALDH1A1HSD17B10KDM4EPOLB
SCHEMBL12926042 0.72 NR2E1 (0.59) HPGDALDH1A1KDM4EPOLBMAPK1
SCHEMBL19396257 0.70 L3MBTL3 (0.62) HPGDALDH1A1
SCHEMBL12589841 0.69 ALDH1A1 (0.46) ALDH1A1KDM4EMAPK1MAPTTSHR
SCHEMBL19396275 0.68 ALDH1A1 (0.43) HPGDALDH1A1KDM4EPOLBMAPT
SCHEMBL12589838 0.68 MAPK14 (0.49) HPGDALDH1A1KDM4EMAPTLMNA
SCHEMBL12589846 0.68 L3MBTL1 (0.51) HPGDALDH1A1KDM4EPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170273968-A1 MAO-B INHIBITORS AND REHABILITATION DART NEUROSCIENCE, LLC 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273968-A1 MAO-B INHIBITORS AND REHABILITATION MAOB, MAOA, HTR2B HPGD 932/4885ALDH1A1 1300/4885HSD17B10 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.